Moderna Inc (MRNA)
54.63
+0.27
(+0.50%)
USD |
NASDAQ |
Nov 01, 16:00
55.00
+0.37
(+0.68%)
After-Hours: 20:00
Moderna Shareholders Equity (Quarterly): 11.71B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 11.71B |
| March 31, 2024 | 12.82B |
| December 31, 2023 | 13.85B |
| September 30, 2023 | 13.46B |
| June 30, 2023 | 16.95B |
| March 31, 2023 | 18.86B |
| December 31, 2022 | 19.12B |
| September 30, 2022 | 17.99B |
| June 30, 2022 | 17.98B |
| March 31, 2022 | 17.08B |
| December 31, 2021 | 14.14B |
| September 30, 2021 | 10.12B |
| June 30, 2021 | 6.704B |
| Date | Value |
|---|---|
| March 31, 2021 | 3.838B |
| December 31, 2020 | 2.561B |
| September 30, 2020 | 2.760B |
| June 30, 2020 | 2.947B |
| March 31, 2020 | 1.641B |
| December 31, 2019 | 1.175B |
| September 30, 2019 | 1.252B |
| June 30, 2019 | 1.339B |
| March 31, 2019 | 1.446B |
| December 31, 2018 | 1.530B |
| September 30, 2018 | 1.076B |
| December 31, 2017 | 625.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.175B
Minimum
Dec 2019
19.12B
Maximum
Dec 2022
10.83B
Average
12.82B
Median
Mar 2024
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 14.24B |
| Merck & Co Inc | 43.58B |
| Pfizer Inc | 87.70B |
| Novavax Inc | -431.71M |
| Amgen Inc | 7.527B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.68B |
| Total Liabilities (Quarterly) | 3.968B |
| Current Ratio | 4.088 |